Rankings
▼
Calendar
PRME Q4 2024 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena
PRME
Prime Medicine, Inc.
$771M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
100.0% margin
Operating Income
-$44M
-2025.7% margin
Net Income
-$42M
-1936.6% margin
EPS (Diluted)
$-0.36
QoQ Revenue Growth
+944.5%
Cash Flow
Operating Cash Flow
$16M
Free Cash Flow
$14M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$298M
Total Liabilities
$144M
Stockholders' Equity
$153M
Cash & Equivalents
$182M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
$2M
$0
—
Operating Income
-$44M
-$68M
+35.0%
Net Income
-$42M
-$66M
+35.6%
← FY 2024
All Quarters
Q1 2025 →